Daily aspirin tied to risk of vision loss, says expert

SENIORS who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, a new European study reports.

The data do not show that aspirin causes vision loss. But the findings are of concern if aspirin somehow exacerbates the eye disorder, researchers say, given how many seniors take it daily for heart disease. "For people who have age-related macular degeneration, it probably isn't wise to recommend taking aspirin," said William Christen of Brigham and Women's Hospital in Boston, who was not involved in this study.

Researchers led by Dr Paulus de Jong at the Netherlands Institute for Neuroscience and Academic Medical Centre collected health and lifestyle information from nearly 4,700 people over age 65.

The study, published in the journal Ophthalmology, included Norwegian, Estonian, British, French, Italian, Greek and Spanish seniors.

Of the 839 people who took aspirin each day, 36 had an advanced form of the disease called wet macular degeneration. This equates to about four out of every 100 daily aspirin users. In comparison, roughly two out of every 100 people who took aspirin less frequently had the same type of macular degeneration.

The wet form of the eye condition, caused by leaking blood vessels in the eye, leads to vision loss in the centre of the eye's field of vision.

The dry form of macular degeneration is more common and less severe, although people still suffer visual impairment. Together, wet and dry macular degeneration make up the leading causes of vision loss among people over age 60, afflicting millions of Americans.

In other words, for people with cardiovascular disease who take aspirin to prevent the condition from worsening, the benefits of the drug outweigh the risks to visual health.

Reuters